Published by Josh White on 12th April 2023
(Sharecast News) - Drug discovery and development company ImmuPharma announced positive progress in its late-stage P140 clinical programme on Tuesday, for patients with chronic idiopathic demyelinating polyneuropathy (CIDP), a rare neurological disease with high medical need.
URL: http://www.digitallook.com/dl/news/story/33429946/...